Group 1 - The core point of the article is that Anke Bio (300009.SZ) announced that senior executive Yao Jianping plans to reduce his shareholding by 1 million shares, which represents 0.06% of the company's total share capital, within a specified timeframe [1] Group 2 - Yao Jianping currently holds 6,762,235 shares, accounting for 0.40% of the company's total share capital [1] - The planned reduction will take place from September 26, 2025, to December 25, 2025, through centralized bidding or block trading [1]

格隆汇9月4日丨国瑞科技(300600.SZ)公布，近日，常熟市国瑞科技股份有限公司收到持股5%以上股东 龚瑞良先生出具的《关于股份减持结果触及1%整数倍的告知函》，获悉龚瑞良先生于2025年7月18日至 2025年9月3日期间，通过集中竞价累计减持公司股份2,422股，占公司总股本的0.0008%，通过大宗交易 减持公司股份3,148,533股，占公司总股本的1.07%。本次权益变动后，龚瑞良先生持有本公司的股份由 58,768,304股减少至55,617,349股，占公司总股本的比例由19.97%减少至18.90%，股东权益变动合计触 及1%的整数倍。 ...

Group 1 - The company, Taixiang Co., Ltd. (301192.SZ), announced that two of its directors and senior executives, Jiang Zaichun and He Huaqing, have communicated their share reduction plans [1] - The total shares held by these directors and senior executives amount to 1,650,000 shares, representing 1.66% of the company's total shares [1] - The planned reduction will occur within three months, starting from September 26, 2025, to December 25, 2025, with a maximum reduction of 412,500 shares, which is 0.42% of the company's total shares [1]

Group 1 - The company Kefa Electric (300407.SZ) announced that its directors and senior management, Wang Chuanqi and Yang Xiang, plan to reduce their holdings by 518,976 shares, which represents 0.1634% of the total share capital [1] - The planned reduction will take place between September 26, 2025, and December 25, 2025 [1] - The total shares held by the aforementioned individuals amount to 2,075,905 shares, accounting for 0.65% of the company's total share capital [1]

Core Viewpoint - 康方生物 has successfully completed the primary placement agreement, with all conditions met as of September 4, 2025, resulting in the issuance of 23.55 million shares at a price of HKD 149.54 per share, which represents approximately 2.56% of the company's expanded issued share capital post-placement [1][1][1] Summary by Category Company Actions - 康方生物 announced the completion of the primary placement agreement, confirming that all conditions have been fulfilled [1] - A total of 23.55 million shares were placed at a price of HKD 149.54 per share [1] Financial Impact - The placement will increase the company's issued share capital by approximately 2.56% following the issuance of the placement shares [1]

| | | 9月5日A股投资避雷针 | | --- | --- | --- | | 类别 | 公司 | 主要内容 | | 股东减持 | 力合微 | 董事冯震罡拟减持不超57万股股份 | | | 爱博医疗 | 自莹合计减持1.9972%公司股份 | | | 普路通 | 股东张云完成减持2%股份 | | | 金河生物 | 控股股东完成减持3%股份 | | | 国瓷材料 | 股东王红拟减持不超300万股 | | | 诺力股份 | 丁毅、毛英拟合计减持不超过2%股份 | | | 国光连锁 | 董事长胡金根拟减持不超过2.49%股份 | | | 拱东医疗 | 实际控制人施慧勇拟合计减持不超过440.99万股 | | | 力鼎光电 | 伊威达合伙减持340. 31万股公司股份 | | | 威胜信息 | 股东邹启明累计减持200万股公司股份 | | | 美迪西 | 股东林长青累计减持95万股公司股份 | | | 爱科赛博 | 李辉、苏红梅等股东累计减持1.9879%公司股份 | | | 嘉和美康 | 弘云久康拟减持不超过1%股份 | | 其他 | 中环海陆 | 终止筹划公司控制权变更事项 股票复牌 | | | 康惠制药 | ...

本次增持计划尚未实施完毕，成都产业资本集团、成都欣天颐将按照增持计划以自有资金继续增持成都 银行股份。 格隆汇9月4日丨成都银行(601838.SH)公布，2025年8月27日至2025年9月4日期间，成都产业资本集团通 过上海证券交易所交易系统以集中竞价的方式累计增持成都银行股份4,775,500股，占成都银行股份总数 的比例为0.1127%，累计增持金额为8,700.10万元（含本次增持计划的首次增持，下同）。目前成都产 业资本集团的持股数量为247,657,086股，持股比例为5.8431%。 2025年8月27日至2025年9月4日期间，成都欣天颐通过上海证券交易所交易系统以集中竞价的方式累计 增持成都银行股份4,364,492股，占成都银行股份总数的比例为0.1030%，累计增持金额为7,959.35万 元。目前成都欣天颐的持股数量为165,298,490股，持股比例为3.9000%。 ...

Core Viewpoint - The company, Lihe Microelectronics (688589.SH), announced that its director, Feng Zhenggang, plans to reduce his shareholding due to personal financial needs, which may impact investor sentiment and stock performance [1] Summary by Relevant Sections - **Share Reduction Plan** - Feng Zhenggang intends to reduce his holdings by up to 570,000 shares, which represents no more than 0.39% of the company's total share capital [1] - The reduction will take place 15 trading days after the announcement and within a three-month period, excluding any periods prohibited by regulatory authorities [1] - **Pricing and Methodology** - The shares will be sold through centralized bidding and block trading, with the selling price determined by the market price at the time of the sale, and not lower than the company's initial public offering price [1]

Core Viewpoint - *ST Lanhuang plans to acquire 50.6329% equity stake in Wuzhong Yiwang Juice Co., Ltd. from Xi'an Chunguang Beverage Co., Ltd. for 0 yuan, with a total investment of 26.9175 million yuan to fulfill the capital contribution obligations [1] Group 1 - The acquisition involves a registered capital of 5 million yuan and an additional 21.9175 million yuan to be allocated to the company's capital reserve [1] - Following the completion of the transaction, Yiwang Juice will become a subsidiary of *ST Lanhuang and will be included in the consolidated financial statements [1]

格隆汇9月4日丨博云新材(002297.SZ)公布，近日，公司收到持股5%以上股东高创投出具的《关于股份 减持计划期限届满的告知函》。截至公告披露日，本次减持计划期限届满，高创投共计减持股份 5,727,400股，减持比例为1%。 ...